The Signature from Messenger RNA Expression Profiling Can Predict Lymph Node Metastasis with High Accuracy for Non-small Cell Lung Cancer

[1]  Jihoon Kim,et al.  ArrayXPath II: mapping and visualizing microarray gene-expression data with biomedical ontologies and integrated biological pathway resources using Scalable Vector Graphics , 2005, Nucleic Acids Res..

[2]  Philip Lijnzaad,et al.  An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas , 2005, Nature Genetics.

[3]  T. Kawase,et al.  Expression of a transcriptional factor, SOX6, in human gliomas , 2004, Brain Tumor Pathology.

[4]  Charles A Powell,et al.  Molecular signatures in biopsy specimens of lung cancer. , 2004, American journal of respiratory and critical care medicine.

[5]  David C. Atkins,et al.  Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  S. Shih,et al.  Ricin Triggers Apoptotic Morphological Changes through Caspase-3 Cleavage of BAT3* , 2004, Journal of Biological Chemistry.

[7]  K. Scheidtmann,et al.  TSG101 Interacts with Apoptosis-antagonizing Transcription Factor and Enhances Androgen Receptor-mediated Transcription by Promoting Its Monoubiquitination* , 2004, Journal of Biological Chemistry.

[8]  Jeong-Sun Seo,et al.  Birth of parthenogenetic mice that can develop to adulthood , 2004, Nature.

[9]  Chunlei Wu,et al.  Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis , 2004, Cancer.

[10]  F. Bertucci,et al.  Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters , 2004, Oncogene.

[11]  Gerhard Christofori,et al.  Cell adhesion and signalling by cadherins and Ig-CAMs in cancer , 2004, Nature Reviews Cancer.

[12]  R. Zeller,et al.  Glypican 4 modulates FGF signalling and regulates dorsoventral forebrain patterning in Xenopus embryos , 2003, Development.

[13]  Makoto Ohnishi,et al.  Identification of potential biomarkers of lymph node metastasis in oral squamous cell carcinoma by cDNA microarray analysis , 2003, International journal of cancer.

[14]  S. Hilsenbeck,et al.  Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer , 2003, The Lancet.

[15]  N. Park,et al.  Senescence-associated genes in normal human oral keratinocytes. , 2003, Experimental cell research.

[16]  Byung-Tae Kim,et al.  Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection prospective study. , 2003, Radiology.

[17]  N. Ferrara,et al.  The biology of VEGF and its receptors , 2003, Nature Medicine.

[18]  R. Kalluri.  Basement membranes: structure, assembly and role in tumour angiogenesis , 2003, Nature reviews. Cancer.

[19]  Yusuke Nakamura,et al.  Expression profiles of non-small cell lung cancers on cDNA microarrays: Identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs , 2003, Oncogene.

[20]  Ivar Siccama,et al.  Genomic profiling of gastric cancer predicts lymph node status and survival , 2003, Oncogene.

[21]  H. Kimura,et al.  Enhanced expression of Mcm proteins in cancer cells derived from uterine cervix. , 2003, European journal of biochemistry.

[22]  Arnulf H Hölscher,et al.  Lymph node size and metastatic infiltration in non-small cell lung cancer. , 2003, Chest.

[23]  M. Copin,et al.  Induction of MUC2 and MUC5AC Mucins by Factors of the Epidermal Growth Factor (EGF) Family Is Mediated by EGF Receptor/Ras/Raf/Extracellular Signal-regulated Kinase Cascade and Sp1* , 2002, The Journal of Biological Chemistry.

[24]  David E. Misek,et al.  Gene-expression profiles predict survival of patients with lung adenocarcinoma , 2002, Nature Medicine.

[25]  K. Alitalo,et al.  Metastasis: Lymphangiogenesis and cancer metastasis , 2002, Nature Reviews Cancer.

[26]  D W Townsend,et al.  Dual-modality PET/CT tomography for clinical oncology. , 2002, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

[27]  D W Townsend,et al.  A combined PET/CT scanner: the choices. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[28]  D Larhammar,et al.  Neuropeptide Y receptor gene y6: multiple deaths or resurrections? , 2000, Biochemical and biophysical research communications.

[29]  J. Crowley,et al.  Induction chemotherapy before surgery for early-stage lung cancer: A novel approach. Bimodality Lung Oncology Team. , 2000, The Journal of thoracic and cardiovascular surgery.

[30]  J. Sunderland,et al.  Mediastinal lymph node staging of non-small-cell lung cancer: a prospective comparison of computed tomography and positron emission tomography. , 1996, The Journal of thoracic and cardiovascular surgery.

[31]  J. Murray,et al.  The American Thoracic Society lymph node map: a CT demonstration. , 1993, European journal of radiology.

[32]  E H Moore,et al.  Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. , 1992, Radiology.

[33]  P. Vogel,et al.  Über den zusammenhang von lymphknotengröße und metastatischem befall der lymphknoten beim Bronchialkarzinom , 1990, Langenbecks Archiv für Chirurgie.

[34]  Douglas C McCrory,et al.  Noninvasive staging of non-small cell lung cancer: a review of the current evidence. , 2003, Chest.

[35]  J. Vansteenkiste,et al.  Clinical prognostic factors in surgically treated stage IIIA-N2 non-small cell lung cancer: analysis of the literature. , 1998, Lung cancer.

[36]  P. Vogel,et al.  [Correlation of lymph node size and metastatic involvement of lymph nodes in bronchial cancer]. , 1990, Langenbecks Archiv fur Chirurgie.